Exelixis (EXEL) Receivables (2012 - 2026)

Exelixis' (EXEL) quarterly Receivables came in at $328.9 million in Q2 2026, up 16.8% year-on-year from $281.6 million in Q2 2025, and up 14.65% quarter-over-quarter from $286.9 million in Q1 2026.

Exelixis (EXEL) Receivables (2012 - 2026) Analysis & Trends

Exelixis' Receivables history runs 15 years deep, the most recent figure standing at $328.9 million for Q2 2026.

  • On a quarterly basis, Receivables rose 16.8% year-over-year to $328.9 million in Q2 2026; TTM through Apr 2026 was $328.9 million, a 16.8% increase from a year earlier, with the FY2026 full-year figure at $286.9 million, up 8.09% from the prior year.
  • Receivables climbed to $328.9 million in Q2 2026 per EXEL's latest filing, from $286.9 million in the prior quarter.
  • Across five years, Receivables topped out at $396.6 million in Q2 2024 and bottomed at $190.6 million in Q2 2022.
  • The 5-year median for Receivables is $248.1 million (2023), against an average of $263.5 million.
  • Across the five-year window, Receivables soared 70.34% in 2024 and declined 26.28% in 2025, its largest moves.
  • Year by year, Receivables stood at $214.8 million in 2022, then increased by 10.53% to $237.4 million in 2023, then climbed by 13.6% to $269.7 million in 2024, then climbed by 14.84% to $309.7 million in 2025, then advanced by 6.21% to $328.9 million in 2026.
  • Per Business Quant, the three latest EXEL Receivables figures stand at $328.9 million (Q2 2026), $286.9 million (Q1 2026), and $309.7 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 328.95 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 328.95 Mn
Jan 2, 2026 286.92 Mn
Oct 3, 2025 309.73 Mn
Jul 4, 2025 292.35 Mn
Apr 4, 2025 281.64 Mn
Jan 3, 2025 265.44 Mn
Sep 27, 2024 269.71 Mn
Jun 28, 2024 396.58 Mn
Mar 29, 2024 240.58 Mn
Dec 29, 2023 237.41 Mn
Sep 29, 2023 248.11 Mn
Jun 30, 2023 232.82 Mn
Mar 31, 2023 233.92 Mn
Dec 30, 2022 214.78 Mn
Sep 30, 2022 215.02 Mn
Jul 1, 2022 235.40 Mn
Apr 1, 2022 190.61 Mn
Dec 31, 2021 282.65 Mn
Oct 1, 2021 179.49 Mn
Jul 2, 2021 181.50 Mn